Related references
Note: Only part of the references are listed.Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer
Upasana Ray et al.
CANCER RESEARCH (2022)
Exploiting LRRC15 as a Novel Therapeutic Target in Cancer
Upasana Ray et al.
CANCER RESEARCH (2022)
LRRC15 antibody-drug conjugates show promise as osteosarcoma therapeutics in preclinical studies
Katherine K. Slemmons et al.
PEDIATRIC BLOOD & CANCER (2021)
In vivo CART cell imaging: Paving the way for success in CART cell therapy
Reona Sakemura et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors
George D. Demetri et al.
CLINICAL CANCER RESEARCH (2021)
Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy
Yaqi Yang et al.
BIOENGINEERED (2021)
Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration
Haichao Tang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy
Claudia X. Dominguez et al.
CANCER DISCOVERY (2020)
LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications
Eytan Ben-Ami et al.
CANCERS (2020)
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
Wei Chang Colin Tan et al.
CANCER COMMUNICATIONS (2020)
Selection of novel human scFvs against cancer antigen IL1RAP by phage and yeast surface display technology
Shixin Duan et al.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT (2020)
Advances in the Production and Batch Reformatting of Phage Antibody Libraries
Rose H. Reader et al.
MOLECULAR BIOTECHNOLOGY (2019)
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates
James W. Purcell et al.
CANCER RESEARCH (2018)
Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications
Ruisi Fu et al.
CHEMMEDCHEM (2018)
Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
Frederike Bensch et al.
NATURE MEDICINE (2018)
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
A. N. Niemeijer et al.
NATURE COMMUNICATIONS (2018)
Immune checkpoint inhibitors for cancer treatment
Junsik Park et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Learning from the tsunami of immune checkpoint inhibitors in 2015
Hampig Raphael Kourie et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Phage display-derived human antibodies in clinical development and therapy
Andre Frenzel et al.
MABS (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Biomarkers in Cancer Immunotherapy
Ton N. Schumacher et al.
CANCER CELL (2015)
ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging
Tove Olafsen et al.
TUMOR BIOLOGY (2012)
Site-Specific, Thiol-Mediated Conjugation of Fluorescent Probes to Cysteine-Modified Diabodies Targeting CD20 or HER2
Shannon J. Sirk et al.
BIOCONJUGATE CHEMISTRY (2008)
Tumor antigen LRRC15 impedes adenoviral infection: Implications for virus-based cancer therapy
Jim O'Prey et al.
JOURNAL OF VIROLOGY (2008)
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
M Stanbrough et al.
CANCER RESEARCH (2006)
High lib mRNA expression in breast carcinomas
K Satoh et al.
DNA RESEARCH (2004)
Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications
T Olafsen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
A novel member of the leucine-rich repeat superfamily induced in rat astrocytes by β-amyloid
K Satoh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
The leucine-rich repeat as a protein recognition motif
B Kobe et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2001)
Share Paper
